drugset / Trial / NCT04303767

The Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Affected Dentine

NCT04303767

Phase 2 Unknown 132 enrolled Hams Hamed Abdelrahman
RandomizedParallel-groupSingle-blindTreatment

Summary

Teeth selected for intervention with Atraumatic Restorative Treatment will receive Glass Ionomer restorations (control) or MI varnish (test) before receiving the Glass Ionomer restoration

Timeline

Start
2020-03-01
Primary completion
2020-08-01
Completion
2021-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Casein phosphopeptide amorphous calcium phosphate Peptide

Indications